Target intelligence / Profile preview

VIRMA mRNA (VIRMA)

Target
VIRMA
Molecular classification
Other
01

Overview

The user-provided name “VRMA mRNA” appears to be a misspelling or variant of VIRMA mRNA, referring to the messenger RNA transcribed from the human VIRMA (Vir like m6A methyltransferase associated) gene. VIRMA encodes a protein component of the RNA N6-methyladenosine (m6A) methyltransferase complex (often termed the m6A “writer” complex), where it acts as an associated/regulatory subunit rather than the catalytic core. It enables RNA binding activity, is involved in mRNA processing, and is localized to the m6A methyltransferase complex, cytosol, and nuclear speckles. Functionally, VIRMA is a key regulator of m6A methylation of mRNAs in the 3′-UTR near the stop codon, recruiting the catalytic subunits METTL3 and METTL14 and thereby guiding site-specific m6A deposition. This activity influences mRNA splicing, RNA processing, and mRNA polyadenylation/alternative polyadenylation. Dysregulation or variation of VIRMA has been associated with hepatocellular carcinoma and Wilms tumor, indicating a role in oncogenesis, although VIRMA mRNA itself is not currently a direct, established drug target like a receptor, ion channel, or enzyme.

Other names
Vir like m6A methyltransferase associatedKIAA1429VIRMA gene transcriptVIRMA messenger RNA
02

Biological functions

mRNA processingRNA N6-methyladenosine (m6A) methylationregulation of mRNA splicingregulation of RNA processingregulation of mRNA polyadenylationRNA binding activityrecruiting the catalytic subunits METTL3 and METTL14guiding site-specific m6A deposition
03

Disease associations

CancerHepatocellular carcinomaWilms tumorOncogenesis
04

Safety considerations

Targeting VIRMA mRNA/protein could broadly affect mRNA processing and m6A methylation, with potential widespread effects on gene expression and cellular viability (inference from its role in global mRNA methylation and processing)
05

Biomarkers

VIRMA mRNA expression as exploratory biomarker of dysregulated m6A RNA methylation in cancers (inferred from association of VIRMA with hepatocellular carcinoma and Wilms tumor)

Beyond the preview

Go deeper on VIRMA mRNA (VIRMA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIRMA mRNA (VIRMA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call